Stock Analysis on Net

Cigna Group (NYSE:CI)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 27, 2025.

Price to Book Value (P/BV)
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Cigna Group, P/BV, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Cigna Group Annual Report.


Share Price Trend
The share price exhibited significant fluctuations over the observed period. Initially, it increased from $41.32 in February 2006 to a peak of $47.5 in February 2007, before sharply declining to $16.39 in February 2009. Following this trough, a steady upward trajectory was observed, with the price reaching $294.65 by February 2023. The price peaked at $336.14 in February 2024 but experienced a slight decline to $302.92 in February 2025, indicating some volatility in the most recent years.
Book Value Per Share (BVPS) Trend
The BVPS showed a generally consistent increase throughout the period, indicating growth in the company’s net asset value per share. It started at $14.76 in February 2006, with minor fluctuations around 2009, where it dipped to $13.25 but then resumed steady growth. The BVPS nearly doubled to $29.12 by February 2012 and continued rising to a peak of $158.11 in February 2024, before slightly decreasing to $149.93 in February 2025. This trend suggests a strengthening balance sheet over the years.
Price-to-Book Value Ratio (P/BV)
The P/BV ratio demonstrated variability corresponding to changes in share price and BVPS. It initially increased from 2.8 in 2006 to 3.21 in 2007, then declined sharply to 1.24 in 2009, reflecting the share price drop amid increased book value volatility. Subsequently, the ratio climbed again, reaching a peak of 3.47 in 2018. After 2018, the ratio declined, hitting a low of 1.46 in 2021, before rising moderately to 2.13 in 2024 and slightly declining to 2.02 in 2025. This ratio indicates varying market valuations relative to the company’s net asset value over time, with periods of both undervaluation and premium valuation.
Overall Insights
The share price experienced notable volatility, particularly with a significant decline around the 2008-2009 financial crisis, followed by a prolonged recovery and growth phase extending into recent years. The consistent increase in BVPS reflects underlying asset growth and improved financial strength. Changes in the P/BV ratio suggest shifts in market sentiment and valuation relative to book value, with evidence of both market undervaluation during crises and premium valuations during growth periods. The slight decrease in share price and BVPS in the latest year may warrant attention to potential emerging challenges or market corrections.

Comparison to Competitors

Cigna Group, P/BV, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)


Comparison to Industry (Health Care)